As environmental issues become ever more pressing, pharmaceutical giant Boehringer Ingelheim is leading a green revolution within its industry, with a special focus on sustainable vaccine production. The company's innovative initiatives extend well beyond the finished vaccine. Boehringer
Upstream bioprocessing is pivotal in biomanufacturing, where cellular systems produce vital therapeutic proteins and biological products. This field is experiencing a surge of innovative methods in response to the increased global demand for biopharmaceuticals driven by rising health concerns.
How Is Tech Innovation Shaping Biopharma Production? The biopharmaceutical industry is experiencing profound change thanks to technological advancements. These innovations are not just fine-tuning existing methods; they're revolutionizing drug development and production. Advanced analytics and
Managing conditions in a bioreactor is critical for successful bioprocessing. This is especially so when dealing with fragile cultures such as CHO cells, where pH levels are crucial for encouraging growth and production. Traditional electrochemical probes have been favored for monitoring pH due to
The biopharmaceutical sector is experiencing rapid innovation as therapies like monoclonal antibodies and gene treatments push towards market approval. The cornerstone for ensuring their market readiness is rigorous and extensive testing, which is a significant growth factor for the
Rising Reliance on AI Decision-Making In a turn of events bringing the complexity of artificial intelligence (AI) to the political forefront, the Australian Senate is critically examining the growing utilization of AI in governmental decision-making processes, particularly within the immigration
